> >>>>Kit iontophorèse
Kit iontophorèse View larger
Previous Next

Kit iontophorèse

Last update : 22/12/2020

Surgical medical device

The iontophoresis kit offered by Horus Pharma includes the following medical devices :

  • Ricrolin®+, a riboflavin-based (0.1%), hypotonic ophthalmic solution for para-surgical use suitable for performing cross-linking procedures by iontophoresis.
  • IONTOFOR CXL: corneal electrode
  • PROTENS ELITE 4848LE: return electrode
  • VEGA LAMP 10mW

More details

More info

Ricrolin®+ Indications :

Ricrolin®+ in combination with a medical device emitting UV-A for ophthalmic use, is indicated in the conservative treatment of keratoconus and ectatic pathologies.
The treatment is particularly indicated for:

  • all forms of corneal ectasia, genetic or iatrogenic.
  • progressive keratoconus (clinically or instrumentally documented) and for anomalies of the cornea.

 

CXL by iontophoresis procedure:

  • EPI-ON procedure: there is no de-epithelialization phase
  • Permeation phase: penetration of riboflavin into the stroma through the application of a low-intensity electric field generated by the I-ON CXL device. By fixing the current to 1mA, the iontophoresis phase lasts only 5 minutes.
  • UV-A irradiation phase provided using the VEGA LAMP 10mW for 9 minutes

Ricrolin® + is a Class IIb Medical Device, CE0373 Marking (ISS) -
Made by SOOFT and distributed by Horus Pharma.
- The IONTOFOR CXL® corneal electrode is a class IIa medical device, CE0051 (IMQ), manufactured by SOOFT and distributed by Horus Pharma.
The PROTENS ELITE 4848LE return electrode is a class I medical device manufactured by BIOPROTECH for SOOFT and distributed by Horus Pharma.
- The ION-CXL® current generator is a class IIB medical device (BIOS) manufactured by IACER and distributed by Horus Pharma. -
"This medical device is a regulated health product which, under this regulation, bears the CE mark" - Read the instruction leaflet carefully before use.